Page 54 - Demo

Chapter 25238. Yasa S, Modica G, Sauvageau E, Kaleem A, Hermey G, Lefrancois S. CLN3 regulates endosomal function by modulating Rab7A-effector interactions. J Cell Sci. Mar 16 2020;133(6)doi:10.1242/jcs.23404739. Schweizer M, Markmann S, Braulke T, Kollmann K. Ultrastructural analysis of neuronal and non-neuronal lysosomal storage in mucolipidosis type II knock-in mice. Ultrastruct Pathol. Oct 2013;37(5):366-72. doi:10.3109/01913123.2013.81068740. Yu SH, Wang T, Wiggins K, et al. Lysosomal cholesterol accumulation contributes to the movement phenotypes associated with NUS1 haploinsufficiency. Genet Med. Mar 17 2021;doi:10.1038/s41436-021-01137-641. Tang BL. Rabs, Membrane Dynamics, and Parkinson’s Disease. J Cell Physiol. Jul 2017;232(7):1626-1633. doi:10.1002/jcp.2571342. Koss DJ, Campesan S, Giorgini F, Outeiro TF. Dysfunction of RAB39B-Mediated Vesicular Trafficking in Lewy Body Diseases. Mov Disord. May 3 2021;doi:10.1002/mds.2860543. Renvoisé B, Chang J, Singh R, et al. Lysosomal abnormalities in hereditary spastic paraplegia types SPG15 and SPG11. Ann Clin Transl Neurol. Jun 1 2014;1(6):379-389. doi:10.1002/acn3.6444. Pozner T, Regensburger M, Engelhorn T, Winkler J, Winner B. Janus-faced spatacsin (SPG11): involvement in neurodevelopment and multisystem neurodegeneration. Brain. Aug 1 2020;143(8):2369-2379. doi:10.1093/brain/awaa09945. Fernandes Filho JA, Shapiro BE. Tay-Sachs disease. Arch Neurol. Sep 2004;61(9):1466-8. doi:10.1001/archneur.61.9.146646. Dubos A, Castells-Nobau A, Meziane H, et al. Conditional depletion of intellectual disability and Parkinsonism candidate gene ATP6AP2 in fly and mouse induces cognitive impairment andneurodegeneration. Hum Mol Genet. Dec 1 2015;24(23):6736-55. doi:10.1093/hmg/ddv38047. Desplats P, Patel P, Kosberg K, et al. Combined exposure to Maneb and Paraquat alters transcriptional regulation of neurogenesis-related genes in mice models of Parkinson’s disease. Mol Neurodegener. Sep 28 2012;7:49. doi:10.1186/1750-1326-7-4948. Fan SP, Lee NC, Lin CH. Novel Phenotype of 6p25 Deletion Syndrome Presenting Juvenile Parkinsonism and Brain Calcification. Mov Disord. May 5 2020;doi:10.1002/mds.2807949. Porta F, Mussa A, Concolino D, Spada M, Ponzone A. Dopamine agonists in dihydropteridine reductase deficiency. Mol Genet Metab. Apr 2012;105(4):582-4. doi:10.1016/j.ymgme.2012.01.01350. Bouchereau J, Huttlin EL, Guarani V, Pichard S, Anikster Y, Schiff M. DNAJC12: A molecular chaperone involved in proteostasis, PKU, biogenic amines metabolism and beyond? Mol Genet Metab. Mar 2018;123(3):285-286. doi:10.1016/j.ymgme.2018.01.00651. Ng J, Barral S, De La Fuente Barrigon C, et al. Gene therapy restores dopamine transporter expression and ameliorates pathology in iPSC and mouse models of infantile parkinsonism. Sci Transl Med. May 19 2021;13(594)doi:10.1126/scitranslmed.aaw156452. Catterall WA. Dravet Syndrome: A Sodium Channel Interneuronopathy. Curr Opin Physiol. Apr 2018;2:42-50. doi:10.1016/j.cophys.2017.12.00753. Tassin J, Durr A, Bonnet AM, et al. Levodopa-responsive dystonia. GTP cyclohydrolase I or parkin mutations? Brain. Jun 2000;123 ( Pt 6):1112-21. doi:10.1093/brain/123.6.111254. Bergoug M, Doudeau M, Godin F, Mosrin C, Vallée B, Bénédetti H. Neurofibromin Structure,Functions and Regulation. Cells. Oct 27 2020;9(11)doi:10.3390/cells911236555. Curtius HC, Niederwieser A, Viscontini M, et al. Serotonin and dopamine synthesis in phenylketonuria. Adv Exp Med Biol. 1981;133:277-91. doi:10.1007/978-1-4684-3860-4_1656. Boot E, Hollak CEM, Huijbregts SCJ, et al. Cerebral dopamine deficiency, plasma monoaminealterations and neurocognitive deficits in adults with phenylketonuria. Psychol Med. Dec 2017;47(16):2854-2865. doi:10.1017/s003329171700139857. Hetzelt K, Kerling F, Kraus C, et al. Early-onset parkinsonism in PPP2R5D-related neurodevelopmental disorder. Eur J Med Genet. Jan 2021;64(1):104123. doi:10.1016/j.ejmg.2020.10412358. Peng XM, Tehranian R, Dietrich P, Stefanis L, Perez RG. α-Synuclein activation of proteinphosphatase 2A reduces tyrosine hydroxylase phosphorylation in dopaminergic cells. Journal of Cell Science. 2005;118(15):3523-3530. doi:10.1242/jcs.02481